Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Yu, Ph.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jairam V, Lee V, Yu JB, Park HS. Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases. Am J Clin Oncol. 2020 Jul 17. PMID: 32694296.
    Citations:    
  2. Peters GW, Decker RH, Park HS, Yu JB, Evans SB. Resident attitudes and benefits of mock oral board examinations in radiation oncology. BMC Med Educ. 2020 Jun 26; 20(1):203. PMID: 32586357.
    Citations:    
  3. Lee V, Jairam V, Yu JB, Park HS. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation. Sci Rep. 2020 Jun 22; 10(1):10084. PMID: 32572113.
    Citations:    
  4. Ghabili K, Park HS, Yu JB, Sprenkle PC, Kim SP, Nguyen KA, Ma X, Gross CP, Leapman MS. National trends in the management of patients with positive surgical margins at radical prostatectomy. World J Urol. 2020 Jun 19. PMID: 32562045.
    Citations:    
  5. Liang Y, Muhammad W, Hart GR, Nartowt BJ, Chen ZJ, Yu JB, Roberts KB, Duncan JS, Deng J. A general-purpose Monte Carlo particle transport code based on inverse transform sampling for radiotherapy dose calculation. Sci Rep. 2020 Jun 17; 10(1):9808. PMID: 32555530.
    Citations:    
  6. Mahal AR, Cramer LD, Wang EH, Wang S, Davidoff AJ, Gross CP, Yu JB. Did quality of life for older cancer survivors improve with the turn of the century in the United States? J Geriatr Oncol. 2020 Jun 10. PMID: 32535014.
    Citations:    
  7. Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Gao D, Serizawa T, Yomo S, Aiyama H, Higuchi Y, Shuto T, Akabane A, Sato Y, Niranjan A, Faramand AM, Lunsford LD, McInerney J, Tuanquin LC, Zacharia BE, Chiang V, Singh C, Yu JB, Braunstein S, Mathieu D, Touchette CJ, Lee CC, Yang HC, Aizer AA, Cagney DN, Chan MD, Kondziolka D, Bernstein K, Silverman JS, Grills IS, Siddiqui ZA, Yuan JC, Sheehan JP, Cordeiro D, Nosaki K, Seto T, Deibert CP, Verma V, Day S, Halasz LM, Warnick RE, Trifiletti DM, Palmer JD, Attia A, Li B, Cifarelli CP, Brown PD, Vargo JA, Combs S, Kessel KA, Rieken S, Patel S, Guckenberger M, Andratschke N, Kavanagh BD, Robin TP. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. JAMA Oncol. 2020 Jun 04. PMID: 32496550.
    Citations:    
  8. Yu JB, Brock KK, Campbell AM, Chen AB, Diaz R, Escorcia FE, Gupta G, Hrinivich WT, Joseph S, Korpics M, Onderdonk BE, Pandit-Taskar N, Wood BJ, Woodward WA. Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop. Int J Radiat Oncol Biol Phys. 2020 May 17. PMID: 32434040.
    Citations:    
  9. Lehrer EJ, Kishan AU, Yu JB, Trifiletti DM, Showalter TN, Ellis R, Zaorsky NG. Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials. Radiother Oncol. 2020 Jul; 148:235-242. PMID: 32505965.
    Citations:    
  10. Goldberg SB, Schalper KA, Gettinger SN, Mahajan A, Herbst RS, Chiang AC, Lilenbaum R, Wilson FH, Omay SB, Yu JB, Jilaveanu L, Tran T, Pavlik K, Rowen E, Gerrish H, Komlo A, Gupta R, Wyatt H, Ribeiro M, Kluger Y, Zhou G, Wei W, Chiang VL, Kluger HM. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2020 05; 21(5):655-663. PMID: 32251621.
    Citations:    
  11. Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. Prostate Cancer Radiotherapy Recommendations in Response to COVID-19. Adv Radiat Oncol. 2020 Apr 01. PMID: 32292839.
    Citations:    
  12. Mahal AR, Chavez J, Yang DD, Kim DW, Cole AP, Hu JC, Trinh QD, Yu JB, Nguyen PL, Mahal BA. Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care. Am J Clin Oncol. 2020 03; 43(3):163-167. PMID: 31904711.
    Citations:    
  13. Yang DX, Makarov DV, Gross CP, Yu JB. Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening. Cancer Control. 2020 Jan-Dec; 27(1):1073274820902267. PMID: 32003227.
    Citations:    
  14. Park HS, Yu JB. Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use? JAMA Oncol. 2019 Dec 26. PMID: 31876903.
    Citations:    
  15. Jairam V, Yang DX, Yu JB, Park HS. Emergency Department Visits for Opioid Overdoses Among Patients with Cancer. J Natl Cancer Inst. 2019 Dec 17. PMID: 31845985.
    Citations:    
  16. Kann BH, Hicks DF, Payabvash S, Mahajan A, Du J, Gupta V, Park HS, Yu JB, Yarbrough WG, Burtness BA, Husain ZA, Aneja S. Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2020 Apr 20; 38(12):1304-1311. PMID: 31815574.
    Citations:    
  17. Mahal AR, Johung KL, Mahal BA, Nguyen PL, Yu JB. An Update to Changing Patterns of Anal Carcinoma in the United States. Am J Clin Oncol. 2019 12; 42(12):887-897. PMID: 31651454.
    Citations:    
  18. Yu JB, Pollack CE, Herrin J, Soulos PR, Zhu W, Xu X, Gross CP. Peer Influence on Physician Use of Shorter Course External Beam Radiation Therapy for Patients with Breast Cancer. Pract Radiat Oncol. 2020 Mar - Apr; 10(2):75-83. PMID: 31785370.
    Citations:    
  19. Qian JM, Yu JB, Mahajan A, Goldberg SB, Kluger HM, Chiang VLS. Frequent Use of Local Therapy Underscores Need for Multidisciplinary Care in the Management of Patients With Melanoma Brain Metastases Treated With PD-1 Inhibitors. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1113-1118. PMID: 31479702.
    Citations:    
  20. Hayman JA, Dekker A, Feng M, Keole SR, McNutt TR, Machtay M, Martin NE, Mayo CS, Pawlicki T, Smith BD, Kudner R, Dawes S, Yu JB. Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper. Pract Radiat Oncol. 2019 Nov; 9(6):395-401. PMID: 31445187.
    Citations:    
  21. Jairam V, Lee V, Park HS, Thomas CR, Melnick ER, Gross CP, Presley CJ, Adelson KB, Yu JB. Treatment-Related Complications of Systemic Therapy and Radiotherapy. JAMA Oncol. 2019 Jul 01; 5(7):1028-1035. PMID: 30946433.
    Citations:    
  22. Mahal AR, Butler S, Franco I, Muralidhar V, Larios D, Pike LRG, Zhao SG, Sanford NN, Dess RT, Feng FY, D'Amico AV, Spratt DE, Yu JB, Nguyen PL, Rebbeck TR, Mahal BA. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. 2019 10 01; 125(19):3338-3346. PMID: 31251398.
    Citations:    
  23. Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP. Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). Clin Transl Radiat Oncol. 2019 Sep; 18:39-45. PMID: 31341974.
    Citations:    
  24. Jairam V, Kann BH, Park HS, Miccio JA, Beckta JM, Yu JB, Prabhu RS, Gao SJ, Mehta MP, Curran WJ, Bindra RS, Contessa JN, Patel KR. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis. Anticancer Res. 2019 Jun; 39(6):2911-2918. PMID: 31177129.
    Citations:    
  25. Johnson SB, Gross CP, Yu JB. Methodology Flaws and Implications of a Complementary Medicine Study-In Reply. JAMA Oncol. 2019 03 01; 5(3):433. PMID: 30676618.
    Citations:    Fields:    
  26. Johnstone PAS, Peneguy S, Showalter TN, Yu JB. The case for radiotherapy in a Value based environment. Rep Pract Oncol Radiother. 2019 Mar-Apr; 24(2):200-203. PMID: 30833828.
    Citations:    
  27. Singh C, Qian JM, Yu JB, Chiang VL. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases. J Neurosurg. 2019 02 15; 132(2):512-517. PMID: 30771783.
    Citations:    
  28. Beckta JM, Nosrati JD, Yu JB. Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer. Urol Oncol. 2019 09; 37(9):619-627. PMID: 30738746.
    Citations:    
  29. Kim SP, Tilburt JC, Shah ND, Yu JB, Konety B, Nguyen PL, Abouassaly R, Williams SB, Gross CP. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer. Clin Genitourin Cancer. 2019 06; 17(3):e472-e481. PMID: 30827923.
    Citations:    
  30. Yu JB, Beck TF, Anscher MS, Baschnagel AM, Brock KK, Carlson DJ, Dominello MM, Kimple RJ, Knisely JP, Mendonca MS, Mian OY, Singh AK, Moros EG, Keen JC. Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio. Int J Radiat Oncol Biol Phys. 2019 02 01; 103(2):297-304. PMID: 30647006.
    Citations:    Fields:    
  31. Yu JB, Beck TF, Anscher MS, Baschnagel AM, Brock KK, Carlson DJ, Dominello MM, Kimple RJ, Knisely JPS, Mendonca MS, Mian OY, Singh AK, Moros EG, Keen JC. The ASTRO Research Portfolio: Where Do We Go From Here? Int J Radiat Oncol Biol Phys. 2019 02 01; 103(2):308-309. PMID: 30647008.
    Citations:    Fields:    
  32. Leapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. AUTHOR REPLY. Urology. 2019 02; 124:106. PMID: 30784707.
    Citations:    
  33. Kann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, Gross CP, Park HS, Yu JB, Decker RH. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Radiother Oncol. 2019 05; 134:44-49. PMID: 31005223.
    Citations:    
  34. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2019 Feb 01. PMID: 31411981.
    Citations:    
  35. Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR. Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database. Front Oncol. 2018; 8:678. PMID: 30693271.
    Citations:    
  36. Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol. 2019 Feb; 15:46-52. PMID: 30656222.
    Citations:    
  37. Roffman DA, Hart GR, Leapman MS, Yu JB, Guo FL, Ali I, Deng J. Development and Validation of a Multiparameterized Artificial Neural Network for Prostate Cancer Risk Prediction and Stratification. JCO Clin Cancer Inform. 2018 12; 2:1-10. PMID: 30652591.
    Citations:    
  38. Tannenbaum SS, Soulos PR, Herrin J, Pollack CE, Xu X, Christakis NA, Forman HP, Yu JB, Killelea BK, Wang SY, Gross CP. Surgeon peer network characteristics and adoption of new imaging techniques in breast cancer: A study of perioperative MRI. Cancer Med. 2018 12; 7(12):5901-5909. PMID: 30444005.
    Citations:    Fields:    
  39. Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP. Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro Oncol. 2018 11 12; 20(12):1652-1660. PMID: 30418657.
    Citations:    Fields:    
  40. Bledsoe TJ, Park HS, Rutter CE, Aneja S, Nguyen PL, Yu JB. Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States. Am J Clin Oncol. 2018 Nov; 41(11):1062-1068. PMID: 29521648.
    Citations:    Fields:    
  41. Kann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis. Radiother Oncol. 2019 03; 132:188-196. PMID: 30391106.
    Citations:    Fields:    
  42. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. Artificial Intelligence in Radiation Oncology Imaging. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1159-1161. PMID: 30353870.
    Citations:    Fields:    
  43. Kim SP, Gross CP, Shah ND, Tilburt JC, Konety B, Williams SB, Weight CJ, Yu JB, Kumar AMS, Meropol NJ. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists. Ann Surg Oncol. 2019 Feb; 26(2):660-668. PMID: 30311161.
    Citations:    Fields:    
  44. Johnson SB, Park HS, Gross CP, Yu JB. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. JAMA Oncol. 2018 10 01; 4(10):1375-1381. PMID: 30027204.
    Citations:    Fields:    
  45. Chang E, Mougalian SS, Adelson KB, Young MR, Yu JB. Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database. Breast Cancer Res Treat. 2019 Jan; 173(1):209-216. PMID: 30242577.
    Citations:    Fields:    
  46. Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA. Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks. Sci Rep. 2018 09 19; 8(1):14036. PMID: 30232350.
    Citations:    Fields:    
  47. Bukavina L, Tilburt JC, Konety B, Shah ND, Gross CP, Yu JB, Schumacher F, Kutikov A, Smaldone MC, Kim SP. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey. Eur Urol Focus. 2020 Mar 15; 6(2):273-279. PMID: 30219709.
    Citations:    Fields:    
  48. Abu-Khalaf M, Muralikrishnan S, Hatzis C, Canchi D, Yu JB, Chiang V. Breast cancer patients with brain metastasis undergoing GKRS. Breast Cancer. 2019 Mar; 26(2):147-153. PMID: 30182250.
    Citations:    
  49. Kim SP, Meropol NJ, Gross CP, Tilburt JC, Konety B, Yu JB, Abouassaly R, Weight CJ, Williams SB, Shah ND. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists. Urol Oncol. 2018 11; 36(11):501.e15-501.e21. PMID: 30190177.
    Citations:    Fields:    Translation:Humans
  50. Kim SP, Shah ND, Meropol NJ, Tilburt JC, Nguyen PL, Yu JB, Abouassaly R, Kim A, Gross CP. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Eur Urol Oncol. 2019 03; 2(2):189-195. PMID: 31017095.
    Citations:    
  51. Leapman MS, Wang R, Park HS, Yu JB, Weinreb JC, Gross CP, Ma X. Association Between Prostate Magnetic Resonance Imaging and Observation for Low-risk Prostate Cancer. Urology. 2019 02; 124:98-106. PMID: 30107188.
    Citations:    Fields:    
  52. Dominello MM, Keen JC, Beck TF, Bayouth J, Knisely J, Carlson DJ, Mendonca MS, Mian O, Brock KK, Anscher M, Hugo G, Moros EG, Singh AK, Yu JB. Responses to the 2017 "1 Million Gray Question": ASTRO Membership's Opinions on the Most Important Research Question Facing Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):249-250. PMID: 30003995.
    Citations:    Fields:    
  53. Johnson SB, Yu JB. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer. Curr Oncol Rep. 2018 06 30; 20(9):66. PMID: 29959582.
    Citations:    Fields:    
  54. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation? Radiother Oncol. 2018 12; 129(3):421-426. PMID: 29907338.
    Citations: 2     Fields:    
  55. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. The Future of Artificial Intelligence in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):247-248. PMID: 30191856.
    Citations:    Fields:    
  56. Yu JB. The Death Spiral of Cancer and Financial Hardship. JNCI Cancer Spectr. 2018 Apr; 2(2):pky013. PMID: 31360846.
    Citations:    
  57. Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP. Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):845-853. PMID: 29976497.
    Citations: 1     Fields:    
  58. Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma. Front Oncol. 2018; 8:95. PMID: 29670856.
    Citations:    
  59. Maroongroge S, Yu JB. Medicare Cancer Screening in the Context of Clinical Guidelines: 2000 to 2012. Am J Clin Oncol. 2018 04; 41(4):339-347. PMID: 26886947.
    Citations:    Fields:    
  60. Yang DX, Soulos PR, Davis B, Gross CP, Yu JB. Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence. Am J Clin Oncol. 2018 03; 41(3):289-294. PMID: 26808257.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  61. Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer. Am J Clin Oncol. 2018 02; 41(2):152-158. PMID: 26523443.
    Citations:    Fields:    Translation:Humans
  62. Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. J Natl Cancer Inst. 2018 01 01; 110(1). PMID: 28922780.
    Citations: 5     Fields:    Translation:Humans
  63. Stahl JM, Damast S, Bledsoe TJ, An Y, Verma V, Yu JB, Young MR, Lester-Coll NH. Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma. Brachytherapy. 2018 Mar - Apr; 17(2):399-406. PMID: 29275078.
    Citations:    Fields:    Translation:Humans
  64. Mahal BA, Chen YW, Sethi RV, Padilla OA, Yang DD, Chavez J, Muralidhar V, Hu JC, Feng FY, Hoffman KE, Martin NE, Spratt DE, Yu JB, Orio PF, Nguyen PL. Travel distance and stereotactic body radiotherapy for localized prostate cancer. Cancer. 2018 03 15; 124(6):1141-1149. PMID: 29231964.
    Citations: 1     Fields:    
  65. Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB. Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. J Natl Compr Canc Netw. 2017 12; 15(12):1494-1502. PMID: 29223987.
    Citations: 2     Fields:    Translation:Humans
  66. Yu JB, Hamstra D. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery. Oncology (Williston Park). 2017 11 15; 31(11):830-2, 835. PMID: 29179251.
    Citations:    Fields:    Translation:Humans
  67. Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, Abrams RA, Shu HG, Curran WJ, Crocker IR, Patel KR. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2018 Jan; 136(2):289-298. PMID: 29124649.
    Citations:    
  68. Mahal AR, Mahal BA, Nguyen PL, Yu JB. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance. Cancer. 2018 02 15; 124(4):752-759. PMID: 29084350.
    Citations: 1     Fields:    
  69. Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiother Oncol. 2017 11; 125(2):258-265. PMID: 29054377.
    Citations:    Fields:    Translation:Humans
  70. Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ. Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study. PLoS One. 2017; 12(9):e0184747. PMID: 28902882.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  71. An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017 10; 125(1):80-88. PMID: 28916225.
    Citations: 3     Fields:    Translation:Humans
  72. Patrice GI, Lester-Coll NH, Yu JB, Amdahl J, Delea TE, Patrice SJ. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST). Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):97-106. PMID: 29029885.
    Citations:    Fields:    Translation:Humans
  73. Corso CD, Park HS, Moreno AC, Kim AW, Yu JB, Husain ZA, Decker RH. Stage I Lung SBRT Clinical Practice Patterns. Am J Clin Oncol. 2017 Aug; 40(4):358-361. PMID: 25503436.
    Citations: 7     Fields:    Translation:Humans
  74. Pollack CE, Soulos PR, Herrin J, Xu X, Christakis NA, Forman HP, Yu JB, Killelea BK, Wang SY, Gross CP. The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer. J Natl Cancer Inst. 2017 08 01; 109(8). PMID: 28376191.
    Citations: 3     Fields:    Translation:Humans
  75. Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018 May - Jun; 8(3):e79-e86. PMID: 28888675.
    Citations: 1     Fields:    Translation:Humans
  76. Johnson SB, Lester-Coll NH, Kelly JR, Kann BH, Yu JB, Nath SK. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer. Eur Urol. 2017 11; 72(5):738-744. PMID: 28688613.
    Citations:    Fields:    Translation:Humans
  77. Rahimy E, Hong JC, Gross CP, Hu X, Soulos PR, Shafman T, Connor HJ, Ross R, Yu JB, Dosoretz A, Evans SB. Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1137-1145. PMID: 28864402.
    Citations: 1     Fields:    Translation:Humans
  78. Jairam V, Yu JB, Aneja S, Wilson LD, Lloyd S. Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type. Am J Clin Oncol. 2017 Jun; 40(3):312-317. PMID: 25374144.
    Citations:    Fields:    Translation:Humans
  79. Magnuson WJ, Lester-Coll NH, Yu JB, Chiang VL. Reply to A. Chalmers et al. J Clin Oncol. 2017 07 10; 35(20):2340-2341. PMID: 28481709.
    Citations:    Fields:    
  80. Yu JB. Hypofractionated Radiotherapy for Prostate Cancer: Further Evidence to Tip the Scales. J Clin Oncol. 2017 06 10; 35(17):1867-1869. PMID: 28355114.
    Citations:    Fields:    
  81. Qian JM, Mahajan A, Yu JB, Tsiouris AJ, Goldberg SB, Kluger HM, Chiang VLS. Comparing available criteria for measuring brain metastasis response to immunotherapy. J Neurooncol. 2017 05; 132(3):479-485. PMID: 28275886.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  82. Kann BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM, Becker KP, Yu JB, Bindra RS, Roberts KB. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro Oncol. 2017 02 01; 19(2):259-269. PMID: 27540083.
    Citations: 3     Fields:    Translation:Humans
  83. Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. J Clin Oncol. 2017 Apr 01; 35(10):1070-1077. PMID: 28113019.
    Citations: 32     Fields:    Translation:Humans
  84. Chen WS, Townsend JP, Yu JB. Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):8-10. PMID: 28587055.
    Citations: 2     Fields:    Translation:Humans
  85. Lester-Coll NH, Johnson S, Magnuson WJ, Goldhaber SZ, Sher DJ, D'Amico AV, Yu JB. Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. J Natl Cancer Inst. 2017 06; 109(6). PMID: 28040795.
    Citations: 2     Fields:    Translation:Humans
  86. Presley CJ, Soulos PR, Tinetti M, Montori VM, Yu JB, Gross CP. Treatment Burden of Medicare Beneficiaries With Stage I Non-Small-Cell Lung Cancer. J Oncol Pract. 2017 02; 13(2):e98-e107. PMID: 27997301.
    Citations: 1     Fields:    Translation:Humans
  87. Lester-Coll NH, Dosoretz AP, Magnuson WJ, Laurans MS, Chiang VL, Yu JB. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. J Neurosurg. 2016 12; 125(Suppl 1):18-25. PMID: 27903191.
    Citations: 2     Fields:    Translation:Humans
  88. Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol. 2016 12; 39(6):568-574. PMID: 24879475.
    Citations: 2     Fields:    Translation:Humans
  89. Kann BH, Yu JB, Stahl JM, Bond JE, Loiselle C, Chiang VL, Bindra RS, Gerrard JL, Carlson DJ. The impact of cobalt-60 source age on biologically effective dose in high-dose functional Gamma Knife radiosurgery. J Neurosurg. 2016 12; 125(Suppl 1):154-159. PMID: 27903196.
    Citations:    
  90. Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Radiother Oncol. 2016 11; 121(2):294-298. PMID: 27890426.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  91. Wang R, Zeidan AM, Yu JB, Soulos PR, Davidoff AJ, Gore SD, Huntington SF, Gross CP, Ma X. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study. Prostate. 2017 04; 77(5):437-445. PMID: 27868212.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  92. Kim SP, Gross CP, Meropol N, Kutikov A, Smaldone MC, Shah ND, Yu JB, Psutka S, Kiechle J, Abouassaly R. National treatment trends among older patients with T1-localized renal cell carcinoma. Urol Oncol. 2017 03; 35(3):113.e15-113.e21. PMID: 27839926.
    Citations: 2     Fields:    Translation:Humans
  93. Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):450-461. PMID: 28011046.
    Citations:    Fields:    Translation:Humans
  94. Yu JB, Mattes M, Thrasher A, Shu HG, De Los Santos JF, Paganetti H, Koontz BF, Abraham C, Balboni TA. Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on National Membership Survey by the American Society for Radiation Oncology (ASTRO). J Clin Oncol. 2016 Oct 09; 34(26_suppl):105. PMID: 28156660.
    Citations:    
  95. Dosoretz AP, Yu JB. Reply to J. Du et al. J Clin Oncol. 2016 12 20; 34(36):4451-4452. PMID: 27621397.
    Citations:    Fields:    
  96. Wang EH, Park HS, Rutter CE, Gross CP, Soulos PR, Yu JB, Evans SB. Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy. Cancer. 2017 02 01; 123(3):502-511. PMID: 27657353.
    Citations:    Fields:    Translation:Humans
  97. Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1011-1020. PMID: 27869080.
    Citations: 2     Fields:    Translation:Humans
  98. Magnuson WJ, Mahal A, Yu JB. Emerging Technologies and Techniques in Radiation Therapy. Semin Radiat Oncol. 2017 01; 27(1):34-42. PMID: 27986210.
    Citations: 2     Fields:    Translation:Humans
  99. Yu JB, Chiang VLS. Reply to timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery. Cancer. 2016 Nov 15; 122(22):3577-3578. PMID: 27495789.
    Citations:    Fields:    
  100. Lester-Coll NH, Park HS, Gross CP, Yu JB. Author Reply. Urology. 2016 10; 96:134-135. PMID: 27492667.
    Citations:    Fields:    
  101. Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? Cancer. 2016 Nov 15; 122(21):3371-3377. PMID: 27434225.
    Citations:    Fields:    Translation:Humans
  102. Colaco RJ, Park HS, Laurans MS, Chiang VS, Yu JB, Husain ZA. Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases. Cureus. 2016 Jul 11; 8(7):e679. PMID: 27563505.
    Citations:    
  103. Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer. Urology. 2016 10; 96:128-135. PMID: 27392652.
    Citations:    Fields:    Translation:Humans
  104. Lester-Coll NH, Dosoretz AP, Hayman JA, Yu JB. Health State Utilities for Patients with Brain Metastases. Cureus. 2016 Jul 04; 8(7):e667. PMID: 27551647.
    Citations: 1     
  105. Wang EH, Yu JB, Abouassally R, Meropol NJ, Cooper G, Shah ND, Williams SB, Gonzalez C, Smaldone MC, Kutikov A, Zhu H, Kim SP. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort. Urology. 2016 Sep; 95:88-94. PMID: 27318264.
    Citations: 7     Fields:    Translation:Humans
  106. Qian JM, Yu JB, Kluger HM, Chiang VL. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery. Cancer. 2016 10; 122(19):3051-8. PMID: 27285122.
    Citations: 24     Fields:    Translation:HumansCells
  107. Wang EH, Yu JB. Chemoradiation Therapy for Organ Preservation in Localized Male Urethral Carcinoma. Oncology (Williston Park). 2016 Jun; 30(6):520-3. PMID: 27306708.
    Citations:    Fields:    Translation:Humans
  108. Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base. Gynecol Oncol. 2016 07; 142(1):54-61. PMID: 27151429.
    Citations: 1     Fields:    Translation:Humans
  109. Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer. 2016 08 01; 122(15):2364-70. PMID: 27172136.
    Citations: 1     Fields:    Translation:Humans
  110. Rosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW, Detterbeck FC, Boffa DJ. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):44-54.e9. PMID: 27131846.
    Citations: 12     Fields:    Translation:Humans
  111. Wang SY, Hsu SH, Gross CP, Sanft T, Davidoff AJ, Ma X, Yu JB. Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis. Value Health. 2016 Jul-Aug; 19(5):631-8. PMID: 27565280.
    Citations: 2     Fields:    Translation:Humans
  112. Konski A, Yu JB, Freedman G, Harrison LB, Johnstone PA. Radiation Oncology Practice: Adjusting to a New Reimbursement Model. J Oncol Pract. 2016 05; 12(5):e576-83. PMID: 27006359.
    Citations: 3     Fields:    Translation:Humans
  113. Dosoretz AP, Yu JB. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer. J Clin Oncol. 2016 05 20; 34(15):1718-22. PMID: 27001587.
    Citations:    Fields:    Translation:Humans
  114. Taylor BF, Knisely JP, Qian JM, Yu JB, Chiang VL. Predicting treatment related imaging changes (TRICs) after radiosurgery for brain metastases using treatment dose and conformality metrics. J Radiosurg SBRT. 2016; 4(1):53-60. PMID: 29296426.
    Citations:    
  115. Rutter CE, Johung KL, Yao X, Lu AY, Jilaveanu LB, Yu JB, Contessa JN, Kluger HM, Chiang VLS, Bindra RS. Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery. J Radiosurg SBRT. 2016; 4(2):97-106. PMID: 29296434.
    Citations:    
  116. Colaco RJ, Yu JB, Bond JS, Bindra RS, Contessa JN, Knisely JPS, Chiang VL. A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases - An initial report. J Radiosurg SBRT. 2016; 4(1):43-52. PMID: 29296425.
    Citations:    
  117. Colaco RJ, Martin P, Kluger HM, Yu JB, Chiang VL. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? J Neurosurg. 2016 07; 125(1):17-23. PMID: 26544782.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  118. Mahal BA, Muralidhar V, Chen YW, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Trinh QD, Nguyen PL. Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9? BJU Int. 2016 Jul; 118(1):95-101. PMID: 26207642.
    Citations: 3     Fields:    Translation:Humans
  119. Bui DL, Yu JB. Trends in Adjuvant and Neoadjuvant Radiotherapy for Cancer Treatment From 1973 to 2011. Cancer J. 2015 May-Jun; 21(3):147-9. PMID: 26049692.
    Citations:    Fields:    Translation:Humans
  120. Jairam V, Chiang VL, Bond J, Yu JB. Equivalent whole brain dose for patients undergoing gamma knife for multiple lesions. J Radiosurg SBRT. 2015; 3(3):187-191. PMID: 29296401.
    Citations:    
  121. Yu JB. The daily miracle of palliative radiotherapy for prostate cancer. Oncology (Williston Park). 2014 Apr; 28(4):261. PMID: 24839796.
    Citations:    Fields:    Translation:Humans
  122. Rutter CE, Yu JB, Carlson DJ, Husain ZA, Zhao S, Picone J, Bindra RS. In regards to decision making for reirradiation of a recurrent intramedullary spinal cord metastasis. J Radiosurg SBRT. 2014; 3(2):165-168. PMID: 29296397.
    Citations:    
  123. Yu JB. Prostate cancer: Interpreting cost-utility analysis of prostate cancer treatment. Nat Rev Urol. 2013 Mar; 10(3):129-31. PMID: 23399726.
    Citations:    Fields:    Translation:Humans
  124. Yu JB. In regard to "Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series." (Int J Radiat Oncol Biol Phys 2012;83:624-629). Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):481. PMID: 22579372.
    Citations:    
  125. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP. The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. J Clin Oncol. 2012 Feb 10; 30(5_suppl):19. PMID: 28142888.
    Citations:    
  126. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP. The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. J Clin Oncol. 2012 Feb 10; 30(5_suppl):108. PMID: 28143061.
    Citations:    
  127. Knisely JP, Yu JB. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int j radiat oncol biol phys 2010;78:1244-1252). Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):957-8; author reply 958. PMID: 21281899.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (252)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.